Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Tyndale

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2006
Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in miceM I Damaj, E C K Siu, E M Sellers, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Simultaneous gas chromatographic determination of methamphetamine, amphetamine and their p-hydroxylated metabolites in plasma and urineS Cheung, H Nolte, S V Otton, et al.
Molecular Pharmacology|September 22, 2000
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smokingY Rao, E Hoffmann, M Zia, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4T Kilicarslan, R L Haining, A E Rettie, et al.
Alcoholism, Clinical and Experimental Research|June 19, 2001
Altered gabaa receptor subunit and splice variant expression in rats treated with chronic intermittent ethanolJ Petrie, D W Sapp, R F Tyndale, et al.
Canadian Journal of Physiology and Pharmacology|November 8, 2001
Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populationsA Gaedigk, W L Casley, R F Tyndale, et al.
Biochemical and Biophysical Research Communications|January 10, 2002
An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 allelesC Xu, Y S Rao, B Xu, et al.
Pharmacogenetics|September 10, 1998
NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populationsA Gaedigk, R F Tyndale, M Jurima-Romet, et al.
Clinical Pharmacology and Therapeutics|March 26, 2010
Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapyC Lerman, C Jepson, E P Wileyto, et al.
Archives of Biochemistry and Biophysics|February 1, 1990
The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteinsH B Niznik, R F Tyndale, F R Sallee, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2006
Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in miceM I Damaj, E C K Siu, E M Sellers, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Simultaneous gas chromatographic determination of methamphetamine, amphetamine and their p-hydroxylated metabolites in plasma and urineS Cheung, H Nolte, S V Otton, et al.
Molecular Pharmacology|September 22, 2000
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smokingY Rao, E Hoffmann, M Zia, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4T Kilicarslan, R L Haining, A E Rettie, et al.
Alcoholism, Clinical and Experimental Research|June 19, 2001
Altered gabaa receptor subunit and splice variant expression in rats treated with chronic intermittent ethanolJ Petrie, D W Sapp, R F Tyndale, et al.
Canadian Journal of Physiology and Pharmacology|November 8, 2001
Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populationsA Gaedigk, W L Casley, R F Tyndale, et al.
Biochemical and Biophysical Research Communications|January 10, 2002
An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 allelesC Xu, Y S Rao, B Xu, et al.
Pharmacogenetics|September 10, 1998
NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populationsA Gaedigk, R F Tyndale, M Jurima-Romet, et al.
Clinical Pharmacology and Therapeutics|March 26, 2010
Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapyC Lerman, C Jepson, E P Wileyto, et al.
Archives of Biochemistry and Biophysics|February 1, 1990
The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteinsH B Niznik, R F Tyndale, F R Sallee, et al.
Pageof 9